| PIERIS PHARMACEUTICALS, INC. |
10%+ Owner |
Common Stock |
129,574 |
$2,057,946 |
$15.88 |
12 Aug 2024 |
By: ADAR1 Partners |
| PIERIS PHARMACEUTICALS, INC. |
10%+ Owner |
Common Stock |
15,067 |
$239,300 |
$15.88 |
12 Aug 2024 |
By: Spearhead Insurance Solutions IDF, LLC - Series ADAR1 |
| Keros Therapeutics, Inc. |
10%+ Owner |
Common Stock |
0 |
$0 |
$17.75 |
15 Oct 2025 |
By ADAR1 Partners, LP |
| Keros Therapeutics, Inc. |
10%+ Owner |
Common Stock |
0 |
$0 |
$17.75 |
15 Oct 2025 |
By ADAR1 SPVI, LP |
| Keros Therapeutics, Inc. |
10%+ Owner |
Common Stock |
0 |
$0 |
$17.75 |
15 Oct 2025 |
By Spearhead Insurance Solutions IDF, LLC |
| Acasti Pharma Inc. |
10%+ Owner |
Class A Common Stock |
959,571 |
|
|
28 Jun 2024 |
By: ADAR1 Partners |
| Keros Therapeutics, Inc. |
10%+ Owner |
Cash Settled Total Return Swaps |
50,000 |
|
|
09 Apr 2025 |
By ADAR1 Partners, LP |
| Keros Therapeutics, Inc. |
10%+ Owner |
Put Option (obligation to buy) |
0 |
|
|
16 May 2025 |
By ADAR1 Partners, LP |
| Keros Therapeutics, Inc. |
10%+ Owner |
Put Option (obligation to buy) |
0 |
|
|
16 May 2025 |
By Spearhead Insurance Solutions IDF, LLC |
| Keros Therapeutics, Inc. |
10%+ Owner |
Put Option (right to sell) |
0 |
|
|
20 Jun 2025 |
By ADAR1 Partners, LP |
| Keros Therapeutics, Inc. |
10%+ Owner |
Put Option (right to sell) |
0 |
|
|
20 Jun 2025 |
By Spearhead Insurance Solutions IDF, LLC |